[
  {
    "ts": null,
    "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
    "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
    "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769203201,
      "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
      "id": 138229361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
      "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94"
    }
  }
]